Retina Roundtable Session 1

Subscribe

In this first session, the experts discuss their standard approach when using ranibizumab (Lucentis, Genentech) to treat their patients with age-related macular degeneration.

Participants include:

Return to Retina Roundtable Podcast Series

Return to Ophthalmology Times Radio